News
Innogen’s Efsubaglutide Alfa Manufacturing Facility Gets ANVISA GMP Certification
The ANVISA GMP certification will help Innogen accelerate the registration and commercial launch of Efsubaglutide alfa across all PIC/S-aligned emerging markets, including Hong Kong, Southeast Asia and Latin America.
imphoenix82
- August 4, 2026
- 0 Comments
- 59 Views
-
